Free Trial

Ontario Teachers Pension Plan Board Sells 11,549 Shares of Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Key Points

  • Ontario Teachers Pension Plan Board has decreased its holdings in Maximus, Inc. by 28.6%, selling 11,549 shares, and now owns approximately 0.05% of the company worth $1,963,000.
  • Maximus reported a quarterly earnings EPS of $2.16, exceeding analyst expectations of $1.39, with revenue of $1.35 billion, a 2.5% increase from the previous year.
  • A quarterly dividend of $0.30 will be paid to shareholders, representing an annual yield of 1.5% and a payout ratio of 23.86%.
  • Want stock alerts on Maximus? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Ontario Teachers Pension Plan Board lessened its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 28.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 28,781 shares of the health services provider's stock after selling 11,549 shares during the period. Ontario Teachers Pension Plan Board owned approximately 0.05% of Maximus worth $1,963,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. UMB Bank n.a. grew its position in Maximus by 70.2% during the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the period. GAMMA Investing LLC grew its position in Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after acquiring an additional 294 shares during the last quarter. NBC Securities Inc. grew its position in Maximus by 114,900.0% during the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after acquiring an additional 1,149 shares during the last quarter. Blue Trust Inc. grew its position in Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after acquiring an additional 303 shares during the last quarter. Finally, LRI Investments LLC grew its holdings in shares of Maximus by 44.1% during the fourth quarter. LRI Investments LLC now owns 1,638 shares of the health services provider's stock worth $122,000 after purchasing an additional 501 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Transactions at Maximus

In related news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Read Our Latest Research Report on MMS

Maximus Price Performance

Shares of Maximus stock traded down $0.07 during midday trading on Tuesday, reaching $82.58. The company had a trading volume of 258,497 shares, compared to its average volume of 564,452. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.65 billion, a price-to-earnings ratio of 15.21 and a beta of 0.60. The stock has a fifty day simple moving average of $71.96 and a 200 day simple moving average of $70.45. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. Maximus's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.74 earnings per share. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio is presently 22.10%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines